AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metmin GZ 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Medios Laboratories Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Metmin GZ 80mg/500mg Tablet

Diabex Duo 80mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo 80mg/500mg tablets should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can elevate blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor; lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carrying a rapid-acting glucose source (e.g., sugary foods or juice) is recommended to counteract hypoglycemia. Alcohol consumption should be limited due to its potential to lower blood sugar. Additional possible side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring, along with blood cell count and liver function tests as advised by your doctor, are necessary.

Primary Ingredients of Metmin GZ 80mg/500mg Tablet

There is no text provided to rewrite.

Uses of Metmin GZ 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Metmin GZ 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metmin GZ 80mg/500mg Tablet should be administered with a meal.

Common Side effects of Metmin GZ 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Metmin GZ 80mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metmin GZ 80mg/500mg tablet should be administered with a meal.

How Metmin GZ 80mg/500mg Tablet works:

Each Metmin GZ 80mg/500mg tablet contains gliclazide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metmin GZ 80mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Metmin GZ 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Metmin GZ 80mg/500mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metmin GZ 80mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. Metmin GZ 80mg/500mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metmin GZ 80mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, a low initial dose is typically recommended, while use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Metmin GZ 80mg/500mg Tablet :

Should you forget to take a Metmin GZ 80mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metmin GZ 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metmin GZ 80mg/500mg Tablet

Metmin GZ 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Metmin GZ 80mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Metmin GZ 80mg/500mg tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Metmin GZ 80mg/500mg tablets can cause lactic acidosis (MALA), a serious, though rare, complication characterized by excessive blood lactic acid. This medical emergency is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Prolonged use of Metmin GZ 80mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metmin GZ 80mg/500mg Tablets are contraindicated in patients with hypersensitivity to any component or excipient. Their use is also contraindicated in individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining alcohol and Metmin GZ 80mg/500mg tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Metmin GZ 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Metmin GZ 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Metmin GZ 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Metmin GZ 80mg/500mg tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This is a rare side effect, but it's crucial to avoid use in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Metmin GZ 80mg/500mg immediately and seek urgent medical attention.
Prolonged use of Metmin GZ 80mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metmin GZ 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol and Metmin GZ 80mg/500mg tablets is unsafe. This combination can lead to dangerously low blood sugar (hypoglycemia) and a higher risk of lactic acidosis.
Metmin GZ 80mg/500mg Tabl...
48
MRP 56
14% off